Introducing pentavalent vaccine in EPI in India: issues involved

T. Jacob John; Jayaprakash Muliyil

doi:10.25259/IJMR_20101324_450

View/Download PDF

Buy Reprints

PDF

Translate this page into:

Correspondence

132 (

4

); 450-453

doi:

10.25259/IJMR_20101324_450

Introducing pentavalent vaccine in EPI in India: issues involved

T. Jacob John, Jayaprakash Muliyil^,

Co-chair of NTAGI 439 Civil Supplies Godown Lane Kamalakshipuram, Vellore, TN, 632 002 tjacobjohn@yahoo.co.in & Chair of NTAGI Subcommittee on Hib Vaccine, Academic Officer Christian Medical College, Vellore, TN, 632 002, India

jpmuliyil@gmail.com

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Fulltext Views
202

PDF downloads
61

View/Download PDF
Download Citations

BibTeX
RIS

Show Sections

Introducing pentavalent vaccine in EPI in India: issues involved

Suggested read for related articles: